Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 7, 2011 - Issue
Submit an article Journal homepage
519
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Patrick Lemoine1 The Clinique Lyon-Lumière, Meyzieu, France
,
Doron Garfinkel2 Geriatric-Palliative Department, Shoham Geriatric Medical Center, Pardes Hanna, Israel
,
Moshe Laudon3 Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel
,
Tali Nir3 Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel
&
Nava Zisapel3 Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel;4 Department of Neurobiology Faculty of Life Sciences, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
Pages 301-311 | Published online: 26 Jul 2011

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.